Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 15, 2012 - Issue 4
182
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Timing of human chorionic gonadotropin trigger, in patients undergoing controlled ovarian hyperstimulation for IVF, using the GnRH antagonist protocol

, M.D.
Page 221 | Received 25 Sep 2012, Accepted 23 Oct 2012, Published online: 28 Nov 2012

References

  • Morley, L., Tang, T., Yasmin, E., Hamzeh, R., Rutherford, A. J., Balen, A. H. (2012). Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial. Human fertility (Cambridge, England), 15, 134–139.
  • Orvieto, R., Zohav, E., Scharf, S., Rabinson, J., Meltcer, S., Anteby, E. Y. et al. (2007). The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology, 23, 72–75.
  • Orvieto, R., Rabinson, J., Meltcer, S., Gemer, O., Anteby, E. Y., Zohav, E. (2008). Does physicians’ experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists? Fertility and sterility, 89, 736–737.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.